265 related articles for article (PubMed ID: 31745706)
1. Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study.
Mooney MA; Bi WL; Cantalino JM; Wu KC; Harris TC; Possatti LL; Juvekar P; Hsu L; Dunn IF; Al-Mefty O; Devlin PM
J Neurooncol; 2020 Jan; 146(1):111-120. PubMed ID: 31745706
[TBL] [Abstract][Full Text] [Related]
2. Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma.
Ware ML; Larson DA; Sneed PK; Wara WW; McDermott MW
Neurosurgery; 2004 Jan; 54(1):55-63; discussion 63-4. PubMed ID: 14683541
[TBL] [Abstract][Full Text] [Related]
3. Resection and permanent intracranial brachytherapy using modular, biocompatible cesium-131 implants: results in 20 recurrent, previously irradiated meningiomas.
Brachman DG; Youssef E; Dardis CJ; Sanai N; Zabramski JM; Smith KA; Little AS; Shetter AG; Thomas T; McBride HL; Sorensen S; Spetzler RF; Nakaji P
J Neurosurg; 2018 Dec; 131(6):1819-1828. PubMed ID: 30579269
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.
Aizer AA; Arvold ND; Catalano P; Claus EB; Golby AJ; Johnson MD; Al-Mefty O; Wen PY; Reardon DA; Lee EQ; Nayak L; Rinne ML; Beroukhim R; Weiss SE; Ramkissoon SH; Abedalthagafi M; Santagata S; Dunn IF; Alexander BM
Neuro Oncol; 2014 Nov; 16(11):1547-53. PubMed ID: 24891451
[TBL] [Abstract][Full Text] [Related]
5. Survival and failure patterns in atypical and anaplastic meningiomas: A single-center experience of surgery and postoperative radiotherapy.
Kumar N; Kumar R; Khosla D; Salunke PS; Gupta SK; Radotra BD
J Cancer Res Ther; 2015; 11(4):735-9. PubMed ID: 26881510
[TBL] [Abstract][Full Text] [Related]
6. Impact of postoperative radiotherapy on recurrence of primary intracranial atypical meningiomas.
Keric N; Kalasauskas D; Freyschlag CF; Gempt J; Misch M; Poplawski A; Lange N; Ayyad A; Thomé C; Vajkoczy P; Meyer B; Ringel F
J Neurooncol; 2020 Jan; 146(2):347-355. PubMed ID: 31900826
[TBL] [Abstract][Full Text] [Related]
7. Is Falcine Meningioma a Diffuse Disease of the Falx? Case Series and Analysis of a "Grade Zero" Resection.
Mooney MA; Abolfotoh M; Bi WL; Tavanaiepour D; Almefty RO; Bassiouni H; Pravdenkova S; Dunn IF; Al-Mefty O
Neurosurgery; 2020 Oct; 87(5):900-909. PubMed ID: 32294205
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
[TBL] [Abstract][Full Text] [Related]
9. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
Rogers L; Zhang P; Vogelbaum MA; Perry A; Ashby LS; Modi JM; Alleman AM; Galvin J; Brachman D; Jenrette JM; De Groot J; Bovi JA; Werner-Wasik M; Knisely JPS; Mehta MP
J Neurosurg; 2018 Jul; 129(1):35-47. PubMed ID: 28984517
[TBL] [Abstract][Full Text] [Related]
10. Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.
Rubino F; Schur S; McGovern SL; Kamiya-Matsuoka C; DeMonte F; Raza SM
J Neurosurg; 2023 Sep; 139(3):798-809. PubMed ID: 36738459
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of radiotherapy and stereotactic radiosurgery as adjuvant or salvage treatment in atypical and anaplastic (WHO grade II and III) meningiomas: a systematic review and meta-analysis.
Gagliardi F; De Domenico P; Snider S; Pompeo E; Roncelli F; Barzaghi LR; Acerno S; Mortini P
Neurosurg Rev; 2023 Mar; 46(1):71. PubMed ID: 36928326
[TBL] [Abstract][Full Text] [Related]
12. Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series.
Magill ST; Lau D; Raleigh DR; Sneed PK; Fogh SE; McDermott MW
Neurosurgery; 2017 Mar; 80(3):409-416. PubMed ID: 27258768
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
14. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
15. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
Hug EB; Devries A; Thornton AF; Munzenride JE; Pardo FS; Hedley-Whyte ET; Bussiere MR; Ojemann R
J Neurooncol; 2000 Jun; 48(2):151-60. PubMed ID: 11083080
[TBL] [Abstract][Full Text] [Related]
16. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
Rosenberg LA; Prayson RA; Lee J; Reddy C; Chao ST; Barnett GH; Vogelbaum MA; Suh JH
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):427-32. PubMed ID: 19427553
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.
El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2018 May; 13(1):86. PubMed ID: 29739417
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.
Lubgan D; Rutzner S; Lambrecht U; Rössler K; Buchfelder M; Eyüpoglu I; Fietkau R; Semrau S
J Neurooncol; 2017 Sep; 134(2):407-416. PubMed ID: 28667597
[TBL] [Abstract][Full Text] [Related]
19. Local control and overall survival in atypical meningioma: a retrospective study.
Goyal LK; Suh JH; Mohan DS; Prayson RA; Lee J; Barnett GH
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):57-61. PubMed ID: 10656373
[TBL] [Abstract][Full Text] [Related]
20. Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection.
Anakwenze CP; McGovern S; Taku N; Liao K; Boyce-Fappiano DR; Kamiya-Matsuoka C; Ghia A; Chung C; Trifiletti D; Ferguson SD; Li J; Yeboa DN
World Neurosurg; 2020 Sep; 141():e133-e144. PubMed ID: 32407910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
